The global chest drainage system market is projected to grow from USD 1.09 billion in 2025 to approximately USD 1.95 billion by 2035, reflecting a CAGR of 6% over the forecast period. This growth is driven by the increasing incidence of respiratory diseases, growing surgical procedures, and the rising awareness about the importance of proper lung care and post-operative recovery.
Chest drainage systems are widely used in hospitals and healthcare settings to treat patients with pleural effusion, pneumothorax, and other conditions that require the removal of air, fluid, or blood from the pleural cavity.
These devices are essential in providing life-saving interventions, especially in emergency and critical care situations. The increasing incidence of lung disorders, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is expected to drive the demand for chest drainage systems during the forecast period.
Innovations in chest drainage system technology have focused on improving patient comfort, ease of use, and the accuracy of fluid drainage. In 2024, Medtronic launched an advanced chest drainage system that integrates smart technology for real-time monitoring and alerts, improving patient safety by notifying healthcare professionals of any complications, such as blockages or air leaks. This technology is expected to significantly enhance patient care and reduce complications associated with traditional chest drainage systems.
Portability and ease of use have become critical factors in the development of modern chest drainage devices, with a growing trend toward single-use systems to prevent cross-contamination and reduce the need for sterilization.
Companies such as Atrium Medical and Smiths Medical have introduced portable, lightweight systems that offer high-efficiency drainage while ensuring that patients remain mobile and comfortable during recovery.
The Asia-Pacific region is expected to experience the highest growth rate in the chest drainage system market, driven by increasing healthcare investments, expanding medical infrastructure, and rising awareness of respiratory health in emerging markets like China and India. North America and Europe will continue to dominate the market due to advanced healthcare systems, high adoption of innovative medical technologies, and a strong regulatory environment.
| Attributes | Description |
|---|---|
| Estimated Chest Drainage System Market Size (2025E) | USD 1.09 billion |
| Projected Chest Drainage System Market Value (2035F) | USD 1.95 billion |
| Value-based CAGR (2025 to 2035) | 6% |
The chest drainage system market is experiencing growth with the pleural drainage systems and pleural effusion indication segments leading the way. Pleural drainage systems account for the largest market share, while pleural effusion is the dominant indication, contributing significantly to the demand for these medical devices. The market is expected to continue expanding as healthcare facilities invest in more advanced drainage solutions.
In 2025, pleural drainage systems are expected to capture 57.4% of the market share, making them the dominant product category in the chest drainage system market. Pleural drainage systems are essential in treating conditions that involve fluid accumulation in the pleural cavity, such as pleural effusion, hemothorax, and spontaneous pneumothorax.
These systems help prevent respiratory complications and allow for the removal of fluids, ensuring better lung function. The increasing prevalence of lung diseases and the growing number of surgical procedures are contributing to the dominance of pleural drainage systems.
Teleflex Incorporated, B. Braun Melsungen AG, and Smiths Medical are key players in the market, providing advanced pleural drainage systems with features such as high-efficiency fluid removal and improved patient safety. With ongoing innovations in technology and increased adoption in healthcare facilities, pleural drainage systems are expected to maintain a significant share of the market through 2025.
The pleural effusion indication is projected to dominate the chest drainage system market, accounting for 36.7% of the market share in 2025. Pleural effusion, characterized by the buildup of excess fluid between the lungs and chest cavity, is a common medical condition that requires effective drainage solutions.
The increasing incidence of pleural effusion due to various underlying health conditions, including heart failure, infections, and cancer, is driving the demand for chest drainage systems.
As a leading indication, pleural effusion treatments contribute significantly to the overall growth of the market. Healthcare providers are increasingly adopting advanced drainage systems to offer more effective solutions for managing pleural effusion.
The growing prevalence of respiratory diseases and advancements in drainage system technologies are key factors propelling the demand. Medtronic, Hollister Incorporated, and Maquet Getinge Group are leaders in providing innovative products to treat pleural effusion, ensuring continued growth in this segment through 2025.
High Cost and Complications
A critical challenge to the chest drainage system market is the cost of advanced devices, especially in low-income and developing countries. This means accessibility becomes limited to medical devices required, thus affecting patient outcomes in low-resource healthcare systems. In addition, there might be complications due to chest drainage such as risks for infection or displacement which may deter some healthcare providers from adopting the advanced systems fully.
Technological Advancements and Rising Demand for Home Healthcare
A lot of opportunities for the growth of the market are being presented by technological developments in the portable and easy-to-use chest drainage systems. As a result, the increasing demand for compact and user-friendly chest drainage systems is anticipated to be driven by the trend toward home healthcare, especially for patients needing long care after surgery. The thoracic surgeries themselves and advances in minimally invasive surgical techniques will strengthen the growth of the market.
The USA chest drainage system market, for example, is exhibiting steady growth through either or both of thoracic surgeries or the increasing incidence of respiratory diseases. The technological advancement of medical science and improved prognosis toward the growing aging populace has provided necessary condition for increasing demand for these systems in hospitals and emergency setups. Adoption, however, will be buoyed by the investment made within the USA healthcare system around emergency medical care infrastructure.
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 6.0% |
The pulmonary diseases linked to the increasing incidences of diseases-aided chronic obstructive pulmonary disease (COPD) and lung cancer-are driving the market behind the expansion of the chest drainage system in the United Kingdom. Increased demand for chest drainage systems is also inspired by the healthcare system in the UK that greatly emphasizes early interventions and management protocols. Advancements made in medical devices and a keen emphasis on patient safety and comfort also add to the growing pace of market growth.
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 5.8% |
The chest drainage system marketin the European Union is being fueled by an aging population and a variegated extend in the prevalence of respiratory diseases across the European Union. The chest surgeries are being performed in increasing numbers in countries such as Germany, France, and Italy and this improves the need for chest drainage systems. The further expansion factor in the market includes stricter strength regulations that secure more suitable patient outcomes.
| Country | CAGR (2025 to 2035) |
|---|---|
| European Union | 6.2% |
The chest drainage system marketin Japan is moderately growing due to the development of healthcare systems in the country for treating thoracic ailments. Surgery for lung disease like lung cancer is picking up, and the elderly population needs effective chest drainage systems. Advanced technologies are being adopted by the Japanese healthcare system for thoracic surgery and patient care, thereby increasing the demand for these devices.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.9% |
In South Korea, chest drainage system marketis on a consistent rise owing to the well-established healthcare infrastructure and increasing incidences of respiratory diseases. Improvement in the quality of thoracic care is one of the initiatives being taken by South Korea, which is likely to spur the demand for advanced chest drainage systems. In addition, developments owing to minimally invasive surgeries-and possibly achieving comfort for the patient-have also invigorated demand in this market.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 6.1% |
Medtronic (30-35%)
Medtronic holds a significant share in the chest drainage system market, leveraging its strong position in the medical device industry. The company is focused on enhancing the functionality and user-friendliness of its products, particularly in critical care settings. Their automated suction regulation and real-time monitoring features have positioned them as a leading innovator in the space.
Smith & Nephew (20-25%)
Smith & Nephew is a key player in the chest drainage market, with a product portfolio that emphasizes patient comfort and safety. The company’s introduction of integrated patient monitoring and easy-to-use systems has made them a preferred choice for healthcare facilities, particularly in the post-surgical recovery phase.
Teleflex Incorporated (15-20%)
Teleflex is recognized for its innovative and high-quality chest drainage solutions. The company’s devices are known for their reliability and safety features, such as built-in valves to prevent backflow. With a strong focus on continuous product improvement, Teleflex’s automated systems are expected to play a significant role in the future of chest drainage care.
Atrium Medical Corporation (10-15%)
Atrium Medical is a trusted name in the chest drainage market, providing solutions with a focus on ease of use and patient safety. Their next-generation drainage systems are well-received in hospitals and surgical centers, and their planned advancements in mobile and remote monitoring systems are expected to further expand their market share.
Other Key Players (15-20% Combined)
| Report Attributes | Details |
|---|---|
| Market Size (2025) | USD 1.09 Billion |
| Projected Market Size (2035) | USD 1.95 Billion |
| CAGR (2025 to 2035) | 6% |
| Base Year for Estimation | 2024 |
| Historical Period | 2020 to 2024 |
| Projections Period | 2025 to 2035 |
| Quantitative Units | USD billion for value and thousand units for volume |
| Product Types Analyzed (Segment 1) | Pleural Drainage Systems, Pleural Drainage Systems Kits, Pleural Drainage Systems Accessories |
| Indications Analyzed (Segment 2) | Pleural Effusion, Hemothorax, Spontaneous Pneumothorax, Tension Pneumothorax, Traumatic Pneumothorax, Cardiac Tamponade, Coronary Artery Bypass Grafting (CABG) Procedures, Open Heart Surgeries |
| End Users Analyzed (Segment 3) | Hospitals, Specialty Clinics, Ambulatory Surgical Centers |
| Regions Covered | North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia Pacific, Middle East & Africa |
| Countries Covered | United States, Canada, Brazil, Mexico, Germany, France, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, GCC Countries, South Africa |
| Key Players influencing the Chest Drainage System Market | Teleflex Incorporated, B. Braun Melsungen AG, Smith’s Medical (ICU Medical Inc.), Becton, Dickinson and Company, Cardinal Health, Redax S.p.A., Merit Medical Systems, Getinge AB, Rocket Medical plc., Grena Ltd., Others |
| Additional Attributes | Sales by product type, Trends in hospital vs outpatient procedures, Growth in post-operative care, Regional differences in drainage system adoption, Innovations in drainage system accessories |
The overall market size for chest drainage system market was USD 1.09 billion in 2025.
The market is expected to reach USD 1.9 billion in 2035.
The demand will be driven by the increasing prevalence of respiratory diseases, growing number of surgeries requiring drainage systems, advancements in medical technology, and rising awareness about post-surgical complications.
The top 5 contributing countries are the United States, Germany, the United Kingdom, Japan, and France.
The single chamber drainage system segment is expected to lead the market due to its simplicity, effectiveness, and cost-efficiency.
Explore Therapeutic Device Insights
Chest Drainage System Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
